Role of membrane lipids in the pulmonary vascular abnormalities caused by bacterial toxins.
D000818:Animals; D002118:Calcium / Q000378:metabolism; D002199:Capillary Permeability / Q000187:drug effects; D003603:Cytotoxins / Q000502:physiology*; D004537:Eicosanoic Acids / Q000096:biosynthesis; D066298:In Vitro Techniques; D008563:Membrane Lipids / Q000502:physiology*; D010743:Phospholipids / Q000378:metabolism; D011453:Prostaglandins / Q000096:biosynthesis; D011550:Pseudomonas aeruginosa; D011652:Pulmonary Circulation / Q000187:drug effects; D011817:Rabbits; D013208:Staphylococcal Toxoid / Q000502:physiology*; D013929:Thromboxane B2 / Q000502:physiology; D014652:Vascular Diseases / Q000139:chemically induced*; D014661:Vasoconstriction
D003603:Cytotoxins; D004537:Eicosanoic Acids; D008563:Membrane Lipids; D010743:Phospholipids; D011453:Prostaglandins; D013208:Staphylococcal Toxoid; D013929:Thromboxane B2; D002118:Calcium